Overview

Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if nalmefene is safe and effective in the treatment of pathological gambling.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Somaxon Pharmaceuticals
Treatments:
Nalmefene
Naltrexone